Warning! GuruFocus detected
6 Severe warning signs
with SVA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Sinovac Biotech Ltd
NAICS : 325412
SIC : 2834
ISIN : AGP8696W1045
Compare
Compare
Traded in other countries / regions
SVA.USASVQ.Germany Index Membership
NASDAQ Golden Dragon China IndexNASDAQ Golden Dragon China IndexNASDAQ Golden Dragon China IndexNASDAQ Golden Dragon China Index IPO Date
2003-09-26Description
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 32.59 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -15.81 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.83 | |||||
| Beneish M-Score | -2.2 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.1 | |||||
| 3-Year Book Growth Rate | 152.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.39 | |||||
| Quick Ratio | 11.24 | |||||
| Cash Ratio | 10.81 | |||||
| Days Inventory | 1706.67 | |||||
| Days Sales Outstanding | 346.24 | |||||
| Days Payable | 5299.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 10.2 | |||||
| Shareholder Yield % | -31.03 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 92.09 | |||||
| Operating Margin % | -84.35 | |||||
| Net Margin % | -29.06 | |||||
| FCF Margin % | -94.31 | |||||
| ROE % | -1.44 | |||||
| ROA % | -0.93 | |||||
| ROIC % | -34.45 | |||||
| 3-Year ROIIC % | -91.56 | |||||
| ROC (Joel Greenblatt) % | -14.52 | |||||
| ROCE % | -1.22 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 0.83 | |||||
| Price-to-Owner-Earnings | 5.43 | |||||
| PS Ratio | 1.5 | |||||
| PB Ratio | 0.05 | |||||
| Price-to-Tangible-Book | 0.05 | |||||
| EV-to-EBIT | 46.07 | |||||
| EV-to-EBITDA | 337.72 | |||||
| EV-to-Revenue | -16.15 | |||||
| EV-to-FCF | 17.12 | |||||
| Price-to-Projected-FCF | 0.02 | |||||
| Price-to-Median-PS-Value | 0.5 | |||||
| Price-to-Net-Current-Asset-Value | 0.07 | |||||
| Price-to-Net-Cash | 0.07 | |||||
| Earnings Yield (Greenblatt) % | 2.17 | |||||
| FCF Yield % | -87.95 | |||||
| Forward Rate of Return (Yacktman) % | 335.02 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinovac Biotech Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 429.204 | ||
| EPS (TTM) ($) | -1.31 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -25.26 | ||
| 3-Year Sortino Ratio | -3.43 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 6.47 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 6.47 - 6.47 | ||
| Shares Outstanding (Mil) | 71.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinovac Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinovac Biotech Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sinovac Biotech Ltd Frequently Asked Questions
What is Sinovac Biotech Ltd(SVA)'s stock price today?
The current price of SVA is $6.47. The 52 week high of SVA is $6.47 and 52 week low is $6.47.
When is next earnings date of Sinovac Biotech Ltd(SVA)?
The next earnings date of Sinovac Biotech Ltd(SVA) is 2025-08-15 Est..
Does Sinovac Biotech Ltd(SVA) pay dividends? If so, how much?
Sinovac Biotech Ltd(SVA) does not pay dividend.
Guru Commentaries on NAS:SVA
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers